Author Biographies

N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dr. Hannah Carolan received her MD from the University of British Columbia in 2000. She completed a Residency in Radiation Oncology at the University of Toronto (2000–2005) and a Fellowship in Radiation Oncology–Breast Cancer at the University of British Columbia (2005–2008). She is a Clinical Associate Professor at the University of British Columbia. She teaches medical students and residents. Her research topics include lung cancer, stereotactic radiation therapy, and toxicity of radiation treatment.
N/A
Dr. Roy Ma received his MD from the University of British Columbia in 1989 and his BSc from the same university in 1985. He completed his Radiation Oncology residency at the B.C. Cancer Agency (1990–1993) and Chief Resident from 1993 to 1994. He has received fellowships from Harvard University Cyclotron Lab (1995) and Loma Linda University Medical Center (1994). He is a Clinical Professor and the current Director of GI Radiation Oncology. His clinical interests include precision radiotherapy, Proton Therapy, and Stereotactic Radiosurgery. He has been actively involved in post-graduate and public education on cancer, particularly within the Chinese community. His research topics include precision radiotherapy, neuro-oncology, GI oncology, and cancer education.
Dr. Alan Nichol received his MD from the University of Calgary in 1993. He completed a Family Practice Residency at Dalhousie University (1993–1995), a Radiation Oncology Residency at the University of British Columbia (1999–2003), and a Clinical Fellowship in Radiation Oncology at the University of Toronto (2003–2004). He is a Clinical Professor at the University of British Columbia and cares for patients with brain tumours and breast cancer at BC Cancer - Vancouver. He teaches medical trainees and graduate students in medical physics. He is the local principal investigator of multiple clinical trials at BC Cancer–Vancouver. His main research areas are radiation treatments for brain metastases and breast cancer radiotherapy.
N/A
N/A
clear